A 2024 Nature Aging study shows IGF1R inhibitors PPP and NVP-ADW742 extend healthspan by 8–12% but cause GI bleeding and cardiotoxicity, questioning their therapeutic potential. A 2024 mouse study r...
Recent studies reveal significant differences in bioactive compounds of CKR between Guangxi and Yunnan, impacting its antithrombotic efficacy and standardization challenges. New research highlights ho...
